TRACON Pharma (NASDAQ:TCON) just reported results for the second quarter of 2024.
- TRACON Pharma reported earnings per share of -94 cents. This was above the analyst estimate for EPS of -$1.05.
- The company reported revenue of $55,000.
Please enter the email address associated with your account and we'll send you a magic link for a password-free sign in.
The provided email address must be associated with an account to receive a login link. If you can't find the email, please check your spam folder.
Enter your existing account details once to link them to this sign-in method.
Not Yet a Premium Subscriber?
Subscribe